Drug Side Effects

Non-Standardized Chemical Allergen [EPC]

Non-Standardized Chemical Allergen [EPC] was reported 22430 times

These side effects are most commonly reported by patients taking drugs of the Non-Standardized Chemical Allergen [EPC] class:

# Drug class Count
0 DRUG INEFFECTIVE 7546
1 ORAL HERPES 2367
2 CONDITION AGGRAVATED 1946
3 DRUG ADMINISTRATION ERROR 1793
4 INCORRECT DRUG ADMINISTRATION DURATION 815
5 EYE IRRITATION 748
6 HERPES SIMPLEX 708
7 PAIN 634
8 PRODUCT QUALITY ISSUE 620
9 INCORRECT PRODUCT ADMINISTRATION DURATION 601
10 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 591
11 MACULAR DEGENERATION 589
12 NAUSEA 577
13 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 573
14 LIP SWELLING 532
15 FATIGUE 515
16 EYE PAIN 494
17 OFF LABEL USE 490
18 HEADACHE 475
19 APPLICATION SITE PAIN 450
20 DIARRHOEA 449
21 VISION BLURRED 443
22 CONSTIPATION 423
23 HYPERSENSITIVITY 420
24 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 406
25 DIZZINESS 366
26 DYSPNOEA 361
27 FALL 358
28 MALAISE 347
29 SWELLING FACE 334
30 RASH 333
31 PRODUCT COMPLAINT 322
32 PYREXIA 315
33 WEIGHT DECREASED 304
34 OCULAR HYPERAEMIA 303
35 PRURITUS 298
36 ERYTHEMA 294
37 VOMITING 285
38 ASTHENIA 282
39 DRY EYE 252
40 APPLICATION SITE ERYTHEMA 248
41 ARTHRALGIA 243
42 ABDOMINAL PAIN 236
43 PRODUCT USE IN UNAPPROVED INDICATION 235
44 APPLICATION SITE IRRITATION 230
45 PNEUMONIA 225
46 HYPOTENSION 220
47 PRODUCT USE ISSUE 219
48 EXPIRED PRODUCT ADMINISTERED 212
49 APPLICATION SITE SWELLING 208
50 BACK PAIN 202
51 INSOMNIA 201
52 PAIN IN EXTREMITY 197
53 ANAEMIA 194
54 BALANCE DISORDER 189
55 DEATH 185
56 COUGH 181
57 ANXIETY 178
58 INJECTION SITE PAIN 178
59 BURNING SENSATION 175
60 LACRIMATION INCREASED 174
61 PARAESTHESIA ORAL 174
62 DYSPEPSIA 168
63 APPLICATION SITE SCAB 165
64 INTENTIONAL DRUG MISUSE 163
65 DRUG HYPERSENSITIVITY 162
66 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 161
67 GAIT DISTURBANCE 160
68 DECREASED APPETITE 157
69 URINARY TRACT INFECTION 157
70 VISUAL IMPAIRMENT 157
71 EYE DISCHARGE 155
72 PARAESTHESIA 154
73 COGNITIVE DISORDER 153
74 FOREIGN BODY SENSATION IN EYES 153
75 FEELING ABNORMAL 150
76 CATARACT 149
77 ORAL DISCOMFORT 147
78 MOBILITY DECREASED 146
79 CHEILITIS 144
80 EYE PRURITUS 143
81 LIP PAIN 141
82 INFUSION RELATED REACTION 140
83 DEPRESSED LEVEL OF CONSCIOUSNESS 139
84 ORTHOSTATIC HYPOTENSION 136
85 HYPOAESTHESIA 135
86 MUSCLE SPASMS 135
87 TOXICITY TO VARIOUS AGENTS 134
88 BLOOD CALCIUM DECREASED 131
89 CHEST PAIN 131
90 LIP DRY 129
91 EYE SWELLING 128
92 BLISTER 127
93 HYPERTENSION 127
94 TREMOR 127
95 ACCIDENTAL EXPOSURE TO PRODUCT 126
96 CREATININE RENAL CLEARANCE DECREASED 125
97 MYALGIA 124
98 PROCEDURAL PAIN 123
99 APPLICATION SITE REACTION 122
100 SEDATION 120
101 ABDOMINAL DISCOMFORT 116
102 ABDOMINAL PAIN UPPER 116
103 CONFUSIONAL STATE 116
104 DEHYDRATION 116
105 NASOPHARYNGITIS 116
106 SOMNOLENCE 115
107 INCORRECT DOSE ADMINISTERED 114
108 CHRONIC SINUSITIS 113
109 DEPRESSION 113
110 SEDATION COMPLICATION 110
111 BLOOD PRESSURE INCREASED 109
112 CEREBROVASCULAR ACCIDENT 109
113 URTICARIA 108
114 CHAPPED LIPS 105
115 HAEMOGLOBIN DECREASED 104
116 APPLICATION SITE SCAR 103
117 PHOTOPHOBIA 101
118 NEUROPATHY PERIPHERAL 100
119 WEIGHT INCREASED 100
120 ALOPECIA 99
121 OEDEMA PERIPHERAL 94
122 DYSPHAGIA 92
123 DRUG DOSE OMISSION 91
124 SCAB 91
125 APPLICATION SITE PRURITUS 90
126 APPLICATION SITE VESICLES 90
127 LIP BLISTER 90
128 OCULAR DISCOMFORT 90
129 SCAR 90
130 ABDOMINAL DISTENSION 88
131 APPLICATION SITE PARAESTHESIA 88
132 CHILLS 88
133 DRY SKIN 88
134 LIP HAEMORRHAGE 88
135 EYE DISORDER 87
136 CONTUSION 86
137 DRY MOUTH 86
138 APPLICATION SITE HAEMORRHAGE 85
139 MUSCULAR WEAKNESS 83
140 NECK PAIN 83
141 THROMBOCYTOPENIA 83
142 APPLICATION SITE DISCOLOURATION 82
143 SINUSITIS 82
144 GASTROOESOPHAGEAL REFLUX DISEASE 81
145 ABNORMAL SENSATION IN EYE 80
146 ACUTE KIDNEY INJURY 80
147 PERIPHERAL SWELLING 80
148 PLATELET COUNT DECREASED 80
149 RHINORRHOEA 80
150 VISUAL ACUITY REDUCED 78
151 HAEMATOCHEZIA 76
152 MIGRAINE 76
153 RENAL FAILURE 76
154 JOINT SWELLING 75
155 SWELLING 75
156 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 74
157 DRUG INTERACTION 74
158 BLOOD GLUCOSE INCREASED 73
159 FEBRILE NEUTROPENIA 73
160 PRODUCT DOSE OMISSION ISSUE 73
161 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 72
162 HAEMORRHAGE 72
163 INFECTION 72
164 LOSS OF CONSCIOUSNESS 72
165 WHITE BLOOD CELL COUNT DECREASED 72
166 RECTAL HAEMORRHAGE 71
167 SEPSIS 71
168 DISEASE PROGRESSION 70
169 DYSGEUSIA 70
170 HYPOAESTHESIA ORAL 70
171 OROPHARYNGEAL PAIN 69
172 SPEECH DISORDER 69
173 THERAPEUTIC RESPONSE UNEXPECTED 69
174 APPLICATION SITE DRYNESS 68
175 PALPITATIONS 68
176 GASTROINTESTINAL HAEMORRHAGE 67
177 MEMORY IMPAIRMENT 66
178 MUSCULOSKELETAL STIFFNESS 66
179 SYNCOPE 66
180 COVID-19 65
181 HYPERHIDROSIS 65
182 STOMATITIS 65
183 INFLUENZA 63
184 RESPIRATORY FAILURE 63
185 HEART RATE INCREASED 62
186 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 62
187 INSTILLATION SITE PAIN 61
188 SCLERAL HYPERAEMIA 60
189 SEIZURE 60
190 EYELID OEDEMA 59
191 ORAL PAIN 59
192 ADVERSE DRUG REACTION 58
193 CELLULITIS 58
194 FREQUENT BOWEL MOVEMENTS 58
195 HOSPITALISATION 58
196 ALANINE AMINOTRANSFERASE INCREASED 57
197 COLITIS 57
198 LIP DISORDER 57
199 ERYTHEMA OF EYELID 56
200 FLUSHING 56
201 ASPARTATE AMINOTRANSFERASE INCREASED 55
202 ATRIAL FIBRILLATION 55
203 RENAL FAILURE ACUTE 55
204 GENERAL PHYSICAL HEALTH DETERIORATION 54
205 INTESTINAL OBSTRUCTION 54
206 ARTHRITIS 53
207 RHEUMATOID ARTHRITIS 53
208 SKIN EXFOLIATION 53
209 ADVERSE EVENT 52
210 ASTHMA 52
211 CHEST DISCOMFORT 52
212 COLITIS ULCERATIVE 52
213 IMPAIRED HEALING 52
214 PNEUMONIA ASPIRATION 52
215 BLOOD CREATININE INCREASED 51
216 INJECTION SITE ERYTHEMA 51
217 BRONCHITIS 50
218 INTENTIONAL PRODUCT MISUSE 50
219 VERTIGO 50
220 LETHARGY 49
221 NEUTROPENIA 49
222 CHRONIC KIDNEY DISEASE 48
223 LIP EXFOLIATION 48
224 OVERDOSE 48
225 AMNESIA 47
226 DEEP VEIN THROMBOSIS 47
227 HALLUCINATION 46
228 MUSCULOSKELETAL PAIN 46
229 PSORIASIS 46
230 RADICULOPATHY 46
231 RENAL IMPAIRMENT 46
232 SKIN DISCOLOURATION 46
233 TACHYCARDIA 46
234 APPLICATION SITE BLEEDING 45
235 APPLICATION SITE BURN 45
236 OSTEOARTHRITIS 45
237 PRODUCT DOSE OMISSION 45
238 PULMONARY EMBOLISM 45
239 CROHN^S DISEASE 44
240 HYPONATRAEMIA 44
241 ORAL CANDIDIASIS 44
242 PRODUCT STORAGE ERROR 44
243 STRESS 44
244 THERAPEUTIC RESPONSE DECREASED 44
245 VAGINAL DISCHARGE 44
246 EAR PAIN 43
247 INFLUENZA LIKE ILLNESS 43
248 INJECTION SITE BRUISING 43
249 SLEEP DISORDER 43
250 SUICIDAL IDEATION 43
251 UPPER RESPIRATORY TRACT INFECTION 43
252 AGITATION 41
253 CARDIAC FAILURE CONGESTIVE 41
254 DRUG EFFECT INCOMPLETE 41
255 DRUG INTOLERANCE 41
256 DYSPHONIA 41
257 EPISTAXIS 41
258 FEMALE GENITAL TRACT FISTULA 41
259 NASAL CONGESTION 41
260 OEDEMA 41
261 POLLAKIURIA 41
262 SKIN LACERATION 41
263 THROMBOSIS 41
264 BLINDNESS 40
265 EYE INFECTION 40
266 HOT FLUSH 40
267 INJECTION SITE HAEMORRHAGE 40
268 LOCAL SWELLING 40
269 MYOCARDIAL INFARCTION 40
270 PANCYTOPENIA 40
271 PROCTITIS 40
272 EMOTIONAL DISTRESS 39
273 FACIAL PAIN 39
274 GASTROINTESTINAL DISORDER 39
275 HAEMORRHOIDS 39
276 HYPOXIA 39
277 MALIGNANT NEOPLASM PROGRESSION 39
278 PRODUCT CONTAINER ISSUE 39
279 PRODUCT SUBSTITUTION ISSUE 39
280 THERAPEUTIC PRODUCT EFFECT DELAYED 39
281 VAGINAL FLATULENCE 39
282 WHEEZING 39
283 ACNE 38
284 FEELING HOT 38
285 INJECTION SITE PRURITUS 38
286 IRRITABILITY 38
287 ANAPHYLACTIC REACTION 37
288 APPLICATION SITE EXFOLIATION 37
289 INTENTIONAL PRODUCT USE ISSUE 37
290 SWOLLEN TONGUE 37
291 UNEVALUABLE EVENT 37
292 DISORIENTATION 36
293 DRUG ADMINISTERED AT INAPPROPRIATE SITE 36
294 FLATULENCE 36
295 INTRAOCULAR PRESSURE INCREASED 36
296 LIP DISCOLOURATION 36
297 NERVOUSNESS 36
298 PRODUCTIVE COUGH 36
299 CARDIAC ARREST 35
300 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 35
301 INFLAMMATION 35
302 LYMPHOCYTE COUNT DECREASED 35
303 PLEURAL EFFUSION 35
304 SKIN IRRITATION 35
305 VITREOUS FLOATERS 35
306 WRONG TECHNIQUE IN DRUG USAGE PROCESS 35
307 EYE INFLAMMATION 34
308 INJURY 34
309 OXYGEN SATURATION DECREASED 34
310 SKIN DISORDER 34
311 CYSTITIS 33
312 DRUG EFFECT DECREASED 33
313 NEPHROLITHIASIS 33
314 SKIN ULCER 33
315 SNEEZING 33
316 APPLICATION SITE INFECTION 32
317 ASTHENOPIA 32
318 BRADYCARDIA 32
319 CARDIAC DISORDER 32
320 DISCOMFORT 32
321 DRUG EFFECT DELAYED 32
322 GLAUCOMA 32
323 LYMPHADENOPATHY 32
324 MENTAL STATUS CHANGES 32
325 RED BLOOD CELL COUNT DECREASED 32
326 ARTHROPATHY 31
327 DIVERTICULITIS 31
328 EXPOSURE DURING PREGNANCY 31
329 HYPOKALAEMIA 31
330 ILL-DEFINED DISORDER 31
331 MEDICATION ERROR 31
332 MOUTH SWELLING 31
333 PAIN IN JAW 31
334 RENAL FAILURE CHRONIC 31
335 SKIN BURNING SENSATION 31
336 THROAT IRRITATION 31
337 WHITE BLOOD CELL COUNT INCREASED 31
338 WOUND 31
339 BLOOD PRESSURE DECREASED 30
340 INTERSTITIAL LUNG DISEASE 30
341 MENTAL DISORDER 30
342 NEURALGIA 30
343 PHARMACEUTICAL PRODUCT COMPLAINT 30
344 PRODUCT PACKAGE ASSOCIATED INJURY 30
345 APPLICATION SITE RASH 29
346 DRUG EFFECT LESS THAN EXPECTED 29
347 DYSURIA 29
348 EYELIDS PRURITUS 29
349 FUNGAL INFECTION 29
350 HIP FRACTURE 29
351 ILLNESS 29
352 NONSPECIFIC REACTION 29
353 PRODUCT ADMINISTRATION ERROR 29
354 BLOOD ALKALINE PHOSPHATASE INCREASED 28
355 BLOOD UREA INCREASED 28
356 DEVICE MALFUNCTION 28
357 DIABETES MELLITUS 28
358 DYSKINESIA 28
359 GASTRIC DISORDER 28
360 HERPES ZOSTER 28
361 HYPERKALAEMIA 28
362 HYPOPHAGIA 28
363 HYPOTHYROIDISM 28
364 LOWER RESPIRATORY TRACT INFECTION 28
365 PRODUCT USE COMPLAINT 28
366 RASH MACULAR 28
367 SEPTIC SHOCK 28
368 TINNITUS 28
369 BLOOD POTASSIUM DECREASED 27
370 BONE PAIN 27
371 CONVULSION 27
372 DEPRESSED MOOD 27
373 DIPLOPIA 27
374 DISTURBANCE IN ATTENTION 27
375 HAEMATURIA 27
376 HYPOGLYCAEMIA 27
377 INCORRECT PRODUCT STORAGE 27
378 KERATITIS 27
379 MULTIPLE DRUG THERAPY 27
380 RASH ERYTHEMATOUS 27
381 RASH PRURITIC 27
382 TENDERNESS 27
383 THINKING ABNORMAL 27
384 CONJUNCTIVITIS 26
385 DYSARTHRIA 26
386 EYELID IRRITATION 26
387 HAEMATOCRIT DECREASED 26
388 INJECTION SITE MASS 26
389 LIP ERYTHEMA 26
390 MADAROSIS 26
391 ASCITES 25
392 CARDIAC FAILURE 25
393 DYSSTASIA 25
394 EYELID PTOSIS 25
395 GASTRITIS 25
396 HEAD INJURY 25
397 INJECTION SITE SWELLING 25
398 MULTIPLE SCLEROSIS 25
399 NIGHTMARE 25
400 PRURITUS GENERALISED 25
401 RASH PAPULAR 25
402 SJOGREN^S SYNDROME 25
403 DELIRIUM 24
404 EXPIRED DRUG ADMINISTERED 24
405 EYELID PAIN 24
406 GLOSSODYNIA 24
407 HEPATIC FUNCTION ABNORMAL 24
408 HIATUS HERNIA 24
409 INTERVERTEBRAL DISC PROTRUSION 24
410 IRRITABLE BOWEL SYNDROME 24
411 LOCALISED INFECTION 24
412 MOVEMENT DISORDER 24
413 OSTEOPOROSIS 24
414 RESPIRATORY DISTRESS 24
415 SURGERY 24
416 THERAPY CESSATION 24
417 THROAT TIGHTNESS 24
418 VIRAL INFECTION 24
419 BLOOD CHOLESTEROL INCREASED 23
420 ILEUS 23
421 INTERNATIONAL NORMALISED RATIO INCREASED 23
422 MULTIPLE USE OF SINGLE-USE PRODUCT 23
423 NEOPLASM MALIGNANT 23
424 NEUTROPHIL COUNT DECREASED 23
425 TOOTHACHE 23
426 TRANSIENT ISCHAEMIC ATTACK 23
427 AGGRESSION 22
428 APPETITE DISORDER 22
429 BLOOD BILIRUBIN INCREASED 22
430 COMA 22
431 HAEMORRHAGIC DIATHESIS 22
432 HYPERGLYCAEMIA 22
433 LEUKOPENIA 22
434 PALLOR 22
435 PANIC ATTACK 22
436 THERAPY INTERRUPTED 22
437 ADVERSE REACTION 21
438 ANGER 21
439 APHASIA 21
440 APPLICATION SITE DISCHARGE 21
441 BLEPHARITIS 21
442 CEREBRAL INFARCTION 21
443 CHOLELITHIASIS 21
444 HYPERSOMNIA 21
445 NO ADVERSE EVENT 21
446 PLASMA CELL MYELOMA 21
447 RASH GENERALISED 21
448 RENAL DISORDER 21
449 ROAD TRAFFIC ACCIDENT 21
450 SKIN LESION 21
451 TREATMENT NONCOMPLIANCE 21
452 UNDERDOSE 21
453 URINARY RETENTION 21
454 ARRHYTHMIA 20
455 C-REACTIVE PROTEIN INCREASED 20
456 EYE HAEMORRHAGE 20
457 EYE OPERATION COMPLICATION 20
458 FAECES DISCOLOURED 20
459 FEAR 20
460 FEELING COLD 20
461 HAEMATEMESIS 20
462 HAEMOPTYSIS 20
463 HEPATIC ENZYME INCREASED 20
464 INJECTION SITE REACTION 20
465 LIP PRURITUS 20
466 OEDEMA MOUTH 20
467 RETCHING 20
468 ABNORMAL BEHAVIOUR 19
469 ACTIVITIES OF DAILY LIVING IMPAIRED 19
470 APPLICATION SITE HYPOAESTHESIA 19
471 APPLICATION SITE INFLAMMATION 19
472 BLOOD ALBUMIN DECREASED 19
473 CLOSTRIDIUM DIFFICILE INFECTION 19
474 COAGULOPATHY 19
475 CORNEAL DISORDER 19
476 CRYING 19
477 DERMATITIS 19
478 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 19
479 DYSPHORIA 19
480 EATING DISORDER 19
481 ECZEMA 19
482 ELECTROCARDIOGRAM QT PROLONGED 19
483 JAUNDICE 19
484 MEDICATION RESIDUE PRESENT 19
485 MUSCLE TWITCHING 19
486 SENSORY DISTURBANCE 19
487 SLEEP APNOEA SYNDROME 19
488 UPPER GASTROINTESTINAL HAEMORRHAGE 19
489 ATELECTASIS 18
490 BONE DISORDER 18
491 CARPAL TUNNEL SYNDROME 18
492 CEREBRAL HAEMORRHAGE 18
493 DRUG ABUSE 18
494 DRUG DEPENDENCE 18
495 DRUG-INDUCED LIVER INJURY 18
496 FIBROMYALGIA 18
497 FLUID RETENTION 18
498 IMPAIRED WORK ABILITY 18
499 INCORRECT ROUTE OF DRUG ADMINISTRATION 18
500 LIMB DISCOMFORT 18
501 LIVER DISORDER 18
502 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 18
503 NEUTROPHIL COUNT INCREASED 18
504 SPINAL OSTEOARTHRITIS 18
505 THERMAL BURN 18
506 ACUTE RESPIRATORY FAILURE 17
507 APPLICATION SITE DISCOMFORT 17
508 ARTHRITIS INFECTIVE 17
509 BLOOD GLUCOSE DECREASED 17
510 BLOOD LACTATE DEHYDROGENASE INCREASED 17
511 BLOOD PRESSURE FLUCTUATION 17
512 BODY HEIGHT DECREASED 17
513 DEMENTIA 17
514 DERMATITIS CONTACT 17
515 DYSPNOEA EXERTIONAL 17
516 EAR INFECTION 17
517 EYELID MARGIN CRUSTING 17
518 FULL BLOOD COUNT DECREASED 17
519 GASTROENTERITIS VIRAL 17
520 HEART RATE DECREASED 17
521 HORDEOLUM 17
522 JOINT STIFFNESS 17
523 LACERATION 17
524 LIVER FUNCTION TEST ABNORMAL 17
525 MUCOSAL INFLAMMATION 17
526 NIGHT SWEATS 17
527 PANCREATITIS 17
528 PARKINSON^S DISEASE 17
529 PHARYNGEAL OEDEMA 17
530 PHOTOSENSITIVITY REACTION 17
531 PROTEINURIA 17
532 RENAL CYST 17
533 RESTLESS LEGS SYNDROME 17
534 SINUS CONGESTION 17
535 SKIN WARM 17
536 SWELLING OF EYELID 17
537 THERAPY NON-RESPONDER 17
538 ABDOMINAL PAIN LOWER 16
539 AGEUSIA 16
540 ALTERED STATE OF CONSCIOUSNESS 16
541 BLINDNESS UNILATERAL 16
542 BLOOD PRESSURE SYSTOLIC INCREASED 16
543 CANDIDA INFECTION 16
544 CLOSTRIDIUM DIFFICILE COLITIS 16
545 EJECTION FRACTION DECREASED 16
546 HALLUCINATION, VISUAL 16
547 JOINT INJURY 16
548 LEUKOCYTOSIS 16
549 MOOD SWINGS 16
550 MUSCULOSKELETAL DISCOMFORT 16
551 NEPHROGENIC ANAEMIA 16
552 NERVOUS SYSTEM DISORDER 16
553 PHOTOPSIA 16
554 PULMONARY OEDEMA 16
555 REACTION TO PRESERVATIVES 16
556 SKIN CANCER 16
557 ABASIA 15
558 ACCIDENTAL OVERDOSE 15
559 ANGIOEDEMA 15
560 APHONIA 15
561 BLOOD SODIUM DECREASED 15
562 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 15
563 CYST 15
564 DECUBITUS ULCER 15
565 DISEASE RECURRENCE 15
566 DISSEMINATED INTRAVASCULAR COAGULATION 15
567 DRUG WITHDRAWAL SYNDROME 15
568 EMOTIONAL DISORDER 15
569 GAIT INABILITY 15
570 GASTROINTESTINAL PAIN 15
571 HYPERAESTHESIA 15
572 HYPOACUSIS 15
573 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 15
574 LIMB INJURY 15
575 LUNG DISORDER 15
576 MULTIPLE SCLEROSIS RELAPSE 15
577 NAIL DISORDER 15
578 NASAL DISCOMFORT 15
579 ORAL MUCOSAL BLISTERING 15
580 PERICARDIAL EFFUSION 15
581 PRODUCT PACKAGING ISSUE 15
582 PRODUCT PACKAGING QUANTITY ISSUE 15
583 PULMONARY MASS 15
584 RASH MACULO-PAPULAR 15
585 RENAL FUNCTION TEST ABNORMAL 15
586 RESTLESSNESS 15
587 SINUS DISORDER 15
588 SKIN REACTION 15
589 ULCERATIVE KERATITIS 15
590 WITHDRAWAL SYNDROME 15
591 APPLICATION SITE EROSION 14
592 BLOOD MAGNESIUM DECREASED 14
593 BLOOD URINE PRESENT 14
594 CONJUNCTIVAL HYPERAEMIA 14
595 EYE OPERATION 14
596 GINGIVAL PAIN 14
597 HEAD DISCOMFORT 14
598 INJECTION SITE RASH 14
599 MALNUTRITION 14
600 MASS 14
601 MELAENA 14
602 MENTAL IMPAIRMENT 14
603 MULTI-ORGAN FAILURE 14
604 MUSCLE TIGHTNESS 14
605 MUSCULOSKELETAL CHEST PAIN 14
606 OESOPHAGITIS 14
607 PARANOIA 14
608 PRE-EXISTING CONDITION IMPROVED 14
609 PULMONARY HYPERTENSION 14
610 RESPIRATORY TRACT CONGESTION 14
611 RESPIRATORY TRACT INFECTION 14
612 RETINAL DETACHMENT 14
613 RIB FRACTURE 14
614 THIRST 14
615 TOOTH INFECTION 14
616 VITAMIN D DEFICIENCY 14
617 ANORECTAL DISCOMFORT 13
618 APPLICATION SITE PAPULES 13
619 BODY TEMPERATURE INCREASED 13
620 BREAST CANCER 13
621 CORONARY ARTERY DISEASE 13
622 EPILEPSY 13
623 GASTRIC ULCER 13
624 GLYCOSYLATED HAEMOGLOBIN INCREASED 13
625 GOUT 13
626 HAIR COLOUR CHANGES 13
627 HYPOCALCAEMIA 13
628 INJECTION SITE WARMTH 13
629 LABORATORY TEST ABNORMAL 13
630 LOWER LIMB FRACTURE 13
631 METABOLIC ACIDOSIS 13
632 OSTEOPENIA 13
633 PELVIC PAIN 13
634 PNEUMOTHORAX 13
635 PROCTALGIA 13
636 SCIATICA 13
637 STAPHYLOCOCCAL INFECTION 13
638 TENDONITIS 13
639 THERAPEUTIC PRODUCT EFFECT VARIABLE 13
640 TREATMENT FAILURE 13
641 VITAMIN D DECREASED 13
642 ACUTE MYOCARDIAL INFARCTION 12
643 AGRANULOCYTOSIS 12
644 ANHEDONIA 12
645 ANKLE FRACTURE 12
646 ANOREXIA 12
647 APPLICATION SITE WARMTH 12
648 BLINDNESS TRANSIENT 12
649 BLOOD TRIGLYCERIDES INCREASED 12
650 BRAIN OEDEMA 12
651 CORNEAL ABRASION 12
652 DEVICE DISLOCATION 12
653 DRUG EXPOSURE DURING PREGNANCY 12
654 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 12
655 ECONOMIC PROBLEM 12
656 END STAGE RENAL DISEASE 12
657 EYE MOVEMENT DISORDER 12
658 EYELID DISORDER 12
659 FEEDING DISORDER 12
660 FOREIGN BODY IN EYE 12
661 GAMMA-GLUTAMYLTRANSFERASE INCREASED 12
662 HEART RATE IRREGULAR 12
663 HEPATIC FAILURE 12
664 HERNIA 12
665 HOSPICE CARE 12
666 IMMUNE SYSTEM DISORDER 12
667 LIP INFECTION 12
668 LIP OEDEMA 12
669 LOWER GASTROINTESTINAL HAEMORRHAGE 12
670 MOUTH ULCERATION 12
671 MYELOSUPPRESSION 12
672 NEOPLASM PROGRESSION 12
673 ORAL DISORDER 12
674 OSTEONECROSIS 12
675 PNEUMONIA BACTERIAL 12
676 PRODUCT DELIVERY MECHANISM ISSUE 12
677 PRODUCT PHYSICAL CONSISTENCY ISSUE 12
678 RENAL TUBULAR NECROSIS 12
679 SEASONAL ALLERGY 12
680 SENSATION OF FOREIGN BODY 12
681 SKIN HAEMORRHAGE 12
682 SKIN INFECTION 12
683 SPUTUM DISCOLOURED 12
684 THERAPEUTIC PRODUCT EFFECT DECREASED 12
685 VOLVULUS 12
686 ABNORMAL DREAMS 11
687 BACTERIAL INFECTION 11
688 CARDIOMEGALY 11
689 CONCOMITANT DISEASE AGGRAVATED 11
690 COORDINATION ABNORMAL 11
691 DENTAL CARIES 11
692 DIVERTICULUM 11
693 DRY THROAT 11
694 EYE ALLERGY 11
695 FACE OEDEMA 11
696 FLANK PAIN 11
697 FOOT FRACTURE 11
698 GINGIVAL BLEEDING 11
699 GINGIVAL SWELLING 11
700 HAEMATOMA 11
701 HAEMORRHAGIC ANAEMIA 11
702 HEPATIC STEATOSIS 11
703 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 11
704 INSTILLATION SITE IRRITATION 11
705 JOINT RANGE OF MOTION DECREASED 11
706 KIDNEY INFECTION 11
707 LIVER FUNCTION TEST INCREASED 11
708 METASTASES TO CENTRAL NERVOUS SYSTEM 11
709 MICTURITION URGENCY 11
710 MULTIPLE ALLERGIES 11
711 NODULE 11
712 OSTEOMYELITIS 11
713 PANCREATIC CARCINOMA 11
714 PNEUMONITIS 11
715 QUALITY OF LIFE DECREASED 11
716 RESPIRATORY DISORDER 11
717 SHOCK 11
718 SINUS HEADACHE 11
719 SKIN FISSURES 11
720 SMALL INTESTINAL OBSTRUCTION 11
721 STEVENS-JOHNSON SYNDROME 11
722 TUBULOINTERSTITIAL NEPHRITIS 11
723 ACUTE RESPIRATORY DISTRESS SYNDROME 10
724 ANGINA PECTORIS 10
725 APHTHOUS ULCER 10
726 ARTERIOSCLEROSIS CORONARY ARTERY 10
727 BACTERAEMIA 10
728 BLOOD GLUCOSE ABNORMAL 10
729 BURKHOLDERIA TEST POSITIVE 10
730 CARDIO-RESPIRATORY ARREST 10
731 CHOKING 10
732 CHOLECYSTITIS 10
733 CONJUNCTIVAL HAEMORRHAGE 10
734 CORNEAL EPITHELIUM DEFECT 10
735 CORNEAL TRANSPLANT 10
736 DEVICE DIFFICULT TO USE 10
737 FAECALOMA 10
738 FEMUR FRACTURE 10
739 GINGIVITIS 10
740 HAIR DISORDER 10
741 HAIR TEXTURE ABNORMAL 10
742 HEPATITIS 10
743 HYDRONEPHROSIS 10
744 HYPERKERATOSIS 10
745 HYPERLIPIDAEMIA 10
746 HYPOMAGNESAEMIA 10
747 INJECTION SITE PAPULE 10
748 INTERVERTEBRAL DISC DEGENERATION 10
749 MIDDLE INSOMNIA 10
750 MITRAL VALVE INCOMPETENCE 10
751 MULTIPLE ORGAN DYSFUNCTION SYNDROME 10
752 OROPHARYNGEAL DISCOMFORT 10
753 PAIN OF SKIN 10
754 PERIORBITAL OEDEMA 10
755 PERIORBITAL PAIN 10
756 PERIPHERAL COLDNESS 10
757 PHARYNGITIS 10
758 POOR QUALITY SLEEP 10
759 POST PROCEDURAL COMPLICATION 10
760 RENAL INJURY 10
761 SPINAL FRACTURE 10
762 SQUAMOUS CELL CARCINOMA 10
763 SUBILEUS 10
764 SUICIDE ATTEMPT 10
765 TACHYPNOEA 10
766 THYROID DISORDER 10
767 TONGUE DISORDER 10
768 TRICUSPID VALVE INCOMPETENCE 10
769 TYPE 2 DIABETES MELLITUS 10
770 UNRESPONSIVE TO STIMULI 10
771 UPPER LIMB FRACTURE 10
772 URINARY INCONTINENCE 10
773 URINE OUTPUT DECREASED 10
774 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 10
775 ABNORMAL FAECES 9
776 ACUTE MYELOID LEUKAEMIA 9
777 BASAL CELL CARCINOMA 9
778 BLADDER DISORDER 9
779 BLOOD PHOSPHORUS DECREASED 9
780 BODY TEMPERATURE DECREASED 9
781 BONE MARROW FAILURE 9
782 BRONCHIOLITIS 9
783 CHROMATURIA 9
784 COLITIS ISCHAEMIC 9
785 CORNEAL OEDEMA 9
786 DEAFNESS 9
787 DECREASED INTEREST 9
788 DELUSION 9
789 DEVICE ISSUE 9
790 DEVICE RELATED INFECTION 9
791 ECCHYMOSIS 9
792 ELECTROLYTE IMBALANCE 9
793 EMBOLISM 9
794 ENCEPHALOPATHY 9
795 ERECTILE DYSFUNCTION 9
796 ERUCTATION 9
797 EXOSTOSIS 9
798 EXTRA DOSE ADMINISTERED 9
799 EYELID EXFOLIATION 9
800 FAILURE TO THRIVE 9
801 FEELING DRUNK 9
802 FLUID OVERLOAD 9
803 GALLBLADDER DISORDER 9
804 GASTROENTERITIS 9
805 GENERALISED ERYTHEMA 9
806 HAEMORRHOIDAL HAEMORRHAGE 9
807 HUNGER 9
808 HYPERCALCAEMIA 9
809 HYPERTHYROIDISM 9
810 HYPOVOLAEMIA 9
811 IMMUNODEFICIENCY 9
812 IMMUNOSUPPRESSION 9
813 IMPAIRED DRIVING ABILITY 9
814 INJECTION RELATED REACTION 9
815 INJECTION SITE INDURATION 9
816 INJECTION SITE URTICARIA 9
817 INSTILLATION SITE ERYTHEMA 9
818 INSTILLATION SITE REACTION 9
819 IRON DEFICIENCY ANAEMIA 9
820 METASTASES TO LIVER 9
821 MOOD ALTERED 9
822 MUSCULOSKELETAL DISORDER 9
823 OBSESSIVE-COMPULSIVE DISORDER 9
824 OSTEONECROSIS OF JAW 9
825 OVARIAN CYST 9
826 PARALYSIS 9
827 PERITONITIS 9
828 POST PROCEDURAL INFECTION 9
829 PRODUCT DISPENSING ERROR 9
830 PSEUDOMONAS INFECTION 9
831 PSORIATIC ARTHROPATHY 9
832 PSYCHOTIC DISORDER 9
833 PURULENT DISCHARGE 9
834 PYELONEPHRITIS 9
835 RESPIRATORY ARREST 9
836 RHINITIS ALLERGIC 9
837 SCOLIOSIS 9
838 SPINAL DISORDER 9
839 SUPRAVENTRICULAR TACHYCARDIA 9
840 TOOTH DISORDER 9
841 TOXIC EPIDERMAL NECROLYSIS 9
842 UPPER-AIRWAY COUGH SYNDROME 9
843 VISUAL FIELD DEFECT 9
844 WOUND HAEMORRHAGE 9
845 ACUTE PHOSPHATE NEPHROPATHY 8
846 AORTIC ARTERIOSCLEROSIS 8
847 APPLICATION SITE ANAESTHESIA 8
848 ARTHROPOD BITE 8
849 ASPIRATION 8
850 BLOOD COUNT ABNORMAL 8
851 BLOOD CREATINE PHOSPHOKINASE INCREASED 8
852 BLOOD GLUCOSE FLUCTUATION 8
853 BLOOD POTASSIUM INCREASED 8
854 BUNDLE BRANCH BLOCK LEFT 8
855 CEREBRAL ATROPHY 8
856 COLD SWEAT 8
857 CONJUNCTIVITIS ALLERGIC 8
858 COVID-19 PNEUMONIA 8
859 DISABILITY 8
860 DRUG LEVEL INCREASED 8
861 DRUG PRESCRIBING ERROR 8
862 DRUG TOXICITY 8
863 EAR DISCOMFORT 8
864 EYE INJURY 8
865 FACIAL PARALYSIS 8
866 FACIAL PARESIS 8
867 GASTRIC ULCER HAEMORRHAGE 8
868 HEPATIC CIRRHOSIS 8
869 HISTIOCYTOSIS HAEMATOPHAGIC 8
870 HYPERCHOLESTEROLAEMIA 8
871 HYPERPHOSPHATAEMIA 8
872 HYPOAESTHESIA FACIAL 8
873 HYPOALBUMINAEMIA 8
874 IMPAIRED GASTRIC EMPTYING 8
875 IMPAIRED QUALITY OF LIFE 8
876 INTESTINAL PERFORATION 8
877 KNEE ARTHROPLASTY 8
878 LACTIC ACIDOSIS 8
879 LARGE INTESTINE POLYP 8
880 LIP INJURY 8
881 MACULAR OEDEMA 8
882 MENISCUS INJURY 8
883 MOUTH HAEMORRHAGE 8
884 NEEDLE ISSUE 8
885 NEPHROCALCINOSIS 8
886 NEPHROPATHY 8
887 NERVE COMPRESSION 8
888 NEUROLOGICAL SYMPTOM 8
889 NO THERAPEUTIC RESPONSE 8
890 NORMOCHROMIC NORMOCYTIC ANAEMIA 8
891 OBSTRUCTIVE AIRWAYS DISORDER 8
892 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 8
893 PELVIC FRACTURE 8
894 PERIORBITAL SWELLING 8
895 PIGMENTATION LIP 8
896 PULMONARY CONGESTION 8
897 PUSTULE 8
898 RECALLED PRODUCT ADMINISTERED 8
899 RESPIRATORY SYNCYTIAL VIRUS INFECTION 8
900 RHINITIS 8
901 ROTATOR CUFF SYNDROME 8
902 SECRETION DISCHARGE 8
903 SUBDURAL HAEMATOMA 8
904 SUPERINFECTION 8
905 SYSTEMIC LUPUS ERYTHEMATOSUS 8
906 THERAPY CHANGE 8
907 TOOTH ABSCESS 8
908 TOOTH LOSS 8
909 TRANSFUSION 8
910 WOUND INFECTION 8
911 ABSCESS 7
912 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 7
913 ACUTE HEPATIC FAILURE 7
914 AMMONIA INCREASED 7
915 ANAL ABSCESS 7
916 APATHY 7
917 APPLICATION SITE HYPERAESTHESIA 7
918 APPLICATION SITE INDURATION 7
919 APPLICATION SITE ULCER 7
920 ASTIGMATISM 7
921 ATAXIA 7
922 BARRETT^S OESOPHAGUS 7
923 BEDRIDDEN 7
924 BENIGN PROSTATIC HYPERPLASIA 7
925 BLEPHAROSPASM 7
926 BLOOD CALCIUM INCREASED 7
927 BLOOD CHLORIDE INCREASED 7
928 BLOOD URIC ACID INCREASED 7
929 BURSITIS 7
930 CARTILAGE INJURY 7
931 CATARACT OPERATION 7
932 CORONARY ARTERY OCCLUSION 7
933 CYTOKINE RELEASE SYNDROME 7
934 CYTOMEGALOVIRUS INFECTION 7
935 DEVICE LEAKAGE 7
936 DEVICE USE ISSUE 7
937 DIZZINESS POSTURAL 7
938 EOSINOPHIL COUNT INCREASED 7
939 EUPHORIC MOOD 7
940 FEELING OF DESPAIR 7
941 FLUID INTAKE REDUCED 7
942 FOOD ALLERGY 7
943 GASTRIC HAEMORRHAGE 7
944 GASTROINTESTINAL INFECTION 7
945 GLOMERULAR FILTRATION RATE DECREASED 7
946 GLUCOSE TOLERANCE IMPAIRED 7
947 GROIN PAIN 7
948 HAEMOGLOBIN ABNORMAL 7
949 HEMIPARESIS 7
950 HERPES VIRUS INFECTION 7
951 HIP ARTHROPLASTY 7
952 HYPERTRIGLYCERIDAEMIA 7
953 INFUSION SITE EXTRAVASATION 7
954 INSTILLATION SITE PRURITUS 7
955 INTENTIONAL DOSE OMISSION 7
956 INTENTIONAL MISUSE 7
957 INTESTINAL DILATATION 7
958 LACRIMATION DECREASED 7
959 LARGE INTESTINE PERFORATION 7
960 LEFT VENTRICULAR HYPERTROPHY 7
961 LOCALISED OEDEMA 7
962 LOW DENSITY LIPOPROTEIN INCREASED 7
963 LUNG INFECTION 7
964 LUNG INFILTRATION 7
965 LYMPHOMA 7
966 MAJOR DEPRESSION 7
967 MATERNAL EXPOSURE DURING PREGNANCY 7
968 MUSCLE STRAIN 7
969 MYDRIASIS 7
970 MYELODYSPLASTIC SYNDROME 7
971 NEUROGENIC BLADDER 7
972 NOCTURIA 7
973 OBESITY 7
974 ONYCHOCLASIS 7
975 OVERWEIGHT 7
976 PAPULE 7
977 PLATELET COUNT INCREASED 7
978 POLYP 7
979 POOR QUALITY PRODUCT ADMINISTERED 7
980 POST PROCEDURAL HAEMORRHAGE 7
981 PRESCRIBED OVERDOSE 7
982 PRESYNCOPE 7
983 PROCEDURAL COMPLICATION 7
984 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 7
985 PRODUCT ADMINISTRATION INTERRUPTED 7
986 PRODUCT FORMULATION ISSUE 7
987 PRODUCT PRESCRIBING ERROR 7
988 PRODUCT RESIDUE PRESENT 7
989 PROTEIN URINE PRESENT 7
990 PSYCHOMOTOR HYPERACTIVITY 7
991 PULMONARY FIBROSIS 7
992 RASH PUSTULAR 7
993 RED BLOOD CELL SEDIMENTATION RATE INCREASED 7
994 RESPIRATORY RATE DECREASED 7
995 RESPIRATORY RATE INCREASED 7
996 RHABDOMYOLYSIS 7
997 RHINOVIRUS INFECTION 7
998 SCRATCH 7
999 SECOND PRIMARY MALIGNANCY 7